Stephen G. Dilly

Overview

Stephen G. Dilly received $8M in total compensation, including $350K in salary, at ProNAi Therapeutics in 2020. Stephen Dilly also received an average of $3M at Aimmune Therapeutics from 2014 to 2018.

Related executives

We found 15 more executives who work or worked at ProNAi Therapeutics and Aimmune Therapeutics.

Nick Glover

ProNAi Therapeutics

Chief Executive Officer

Barbara Klencke

ProNAi Therapeutics

Chief Development Officer

Mark Kowalski

ProNAi Therapeutics

Chief Medical Officer

Jayson Dallas

Aimmune Therapeutics

Chief Executive Officer

Andrew Oxtoby

Aimmune Therapeutics

Chief Commercial Officer

Eric Bjerkholt

Aimmune Therapeutics

Chief Financial Officer

Douglas Sheehy

Aimmune Therapeutics

General Counsel

Daniel Adelman

Aimmune Therapeutics

Chief Medical Officer

News

You may also like